Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein. - Shukla S; Chufan EE; Singh S; Skoumbourdis AP; Kapoor K; Boxer MB; Duveau DY; Thomas CJ; Talele TT; Ambudkar SV (Leukemia, 2014)